NIIMBL | AIChE

NIIMBL

NIIMBL, established under the University of Delaware by the Department of Commerce, focuses on enabling more efficient and flexible manufacturing capabilities for existing and emerging biopharmaceutical products, and developing a world-leading biopharmaceutical manufacturing workforce and their roadmap for biomanufacturing. Their roadmap for the manufacturing needs and propose a vision of the future for three key topics areas: (1) Vaccines; (2) Antibody-Drug Conjugates (ADC) and Bi-specific Antibodies; (3) Gene Therapies. Project calls are issues each year, with the Project Call 3.1 deadline on September 10, 2019. View NIIMBL’s various achievements and milestones in their 2018-19 annual report. For more information on membership, please visit https://niimbl.force.com/s/membership-information